Concepedia

Jennifer Ackil

JA

Statistics

Publications

5

Citations

441

H-Index

5

Active since

2018

Affiliations

Massachusetts General Hospital(Current)

Guardant (United States)

Jennifer Ackil is an author at Massachusetts General Hospital specializing in medicine, oncology, and molecular oncology.

Publications per year

2018–2019

5

Publications

5

Treatment with Next-Generation ALK Inhibitors Fuels Plasma <i>ALK</i> Mutation Diversity

Ibiayi Dagogo‐Jack, Marguerite Rooney, Rebecca J. Nagy et al. · Clinical Cancer Research · 2019 · 150 citations · Full text

, , +17

Tracking the Evolution of Resistance to ALK Tyrosine Kinase Inhibitors Through Longitudinal Analysis of Circulating Tumor DNA

Ibiayi Dagogo‐Jack, A. Rose Brannon, Lorin A. Ferris et al. · JCO Precision Oncology · 2018 · 131 citations · Full text

, , +17

Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC

Ibiayi Dagogo‐Jack, Marguerite Rooney, Rebecca J. Nagy et al. · Journal of Thoracic Oncology · 2019 · 94 citations · Full text

, , +9

Efficacy of Alectinib in Patients with ALK-Positive NSCLC and Symptomatic or Large CNS Metastases

Ginger Jiang, Nencyben D Joshipura, Jennifer Ackil et al. · Journal of Thoracic Oncology · 2018 · 52 citations

, , +13

Safety of osimertinib plus chemotherapy in EGFR-mutant NSCLC.

Zofia Piotrowska, Stephen V. Liu, Alona Muzikansky et al. · Journal of Clinical Oncology · 2018 · 14 citations

, , +12

1–5 of 5